Maternal thyroid deficiency and pregnancy complications: implications for population screening
By Walter C. Allan, J. Haddow, G. Palomaki, Josephine Williams, M. Mitchell, R. Hermos, J. Faix, R. Klein. Journal of Medical Screening, 2000
704 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Obstetrics and Gynecology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/16ba753655abce6d4f67a7f7afd4e2eaee4c8fef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- The clinical significance of subclinical thyroid dysfunction. (2008, background): “Thyroid function was evaluated in blood specimens in two prospective studies of 12,000 women in Maine who were 17 wk pregnant (276, 277).”
- Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum (2011, background): “Allan and colleagues (36) also describe an increased risk of fetal death among pregnant women with OH.”
- Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. (2007, result): “These data are supported by other retrospective analysis (131).”
- 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (2011, background): “Therefore, not surprisingly, thyroid autoantibodies can be detected in approximately 30%–60% of pregnant women with an elevated TSH concentration (19,260,261).”